FDA Recalls StellaLife VEGA Oral Care Rinse for Manufacturing Deviations
The FDA is recalling StellaLife VEGA Oral Care Rinse nationwide due to current Good Manufacturing Practice (cGMP) deviations. The manufacturer voluntarily initiated the recall.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II voluntary recall for manufacturing practice deviations with no specific contamination, illness, or injury reported in the source material.
Plain-English summary
StellaLife VEGA Oral Care Rinse (16 fl oz bottles, Peppermint flavor), manufactured by Homeocare Laboratories, Inc., is being recalled nationwide by the FDA. The product was distributed across the United States.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations in the manufacturing process. This is a voluntary recall initiated by the manufacturer. The affected lot numbers and their expiration dates are: 2357B, 2333 (exp. Sep-2); 2367C, 2367D (exp. Nov-23); 2367E, 2367F (exp. Jan-24); 2395A, 2406 (exp. Feb-2); 2395B (exp. Mar-24); and 2395C (exp. Apr-24). Approximately 130,762 bottles were distributed.
If you have purchased this product, do not use it. Contact the manufacturer or your healthcare provider if you have questions. The recall was officially terminated on September 16, 2024.
The recalled product
- Product
- STELLALIFE VEGA ORAL CARE RINSE (RINSE)
- Brand
- STELLALIFE VEGA ORAL CARE RINSE
- Manufacturer
- Homeocare Laboratories, Inc.
- Category
- Drug — Oral Care
- Hazard
- gmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Lot # 2357B
- 2333
- exp. date Sep-2
- 2367C
- 2367D
- exp. date Nov-23
- 2367E
- 2367F
- exp. date Jan-24
- 2395A
- 2406
- exp. date Feb-2
- 2395B
- exp. date Mar-24
- 2395C
- exp. date Apr-24
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27